SANDOSTATIN LAR

Powder and solvent for suspension for injection, 20 mg
RxActive license

Active substance (INN)

octreotide

Pharmaceutical form

Pharmaceutical formPowder and solvent for suspension for injection
Strength20 mg
PackagingUkupno 1 bočica staklena sa 20mg praška za suspenziju za injekciju i 1 napunjeni injekcioni špric sa 2ml rastvarača u kartonskoj kutiji
ManufacturerNovartis Farmaceutica S.A., Spain
Therapeutic groupSystemic hormonal preparations (H01CB02)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateOctober 28, 2025

Analogs in Montenegro

6

Other medicines with the same active substance

OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 30mgMerckle GmbH
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 10mgMerckle GmbH
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 20mgMerckle GmbH
SANDOSTATINRx
Solution for injection/infusion, 0.1mg/mlNovartis Pharma Stein AG
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 10mgNovartis Farmaceutica S.A.
SANDOSTATIN LARRx
Powder and solvent for suspension for injection, 30mgNovartis Farmaceutica S.A.
Source: CInMED register